MEDIZONE INTERNATIONAL INC
10QSB, EX-27, 2000-11-15
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: MEDIZONE INTERNATIONAL INC, 10QSB, 2000-11-15
Next: SCANA CORP, S-3, 2000-11-15



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 JUL-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                            8,918
<SECURITIES>                                          0
<RECEIVABLES>                                         0
<ALLOWANCES>                                          0
<INVENTORY>                                           0
<CURRENT-ASSETS>                                  8,918
<PP&E>                                           25,556
<DEPRECIATION>                                    8,984
<TOTAL-ASSETS>                                   25,490
<CURRENT-LIABILITIES>                           932,049
<BONDS>                                         280,491
                                 0
                                           0
<COMMON>                                        153,616
<OTHER-SE>                                   (1,060,175)
<TOTAL-LIABILITY-AND-EQUITY>                   (906,559)
<SALES>                                               0
<TOTAL-REVENUES>                                      0
<CGS>                                                 0
<TOTAL-COSTS>                                         0
<OTHER-EXPENSES>                                153,361
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                5,610
<INCOME-PRETAX>                                (158,971)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                            (158,971)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                   (158,971)
<EPS-BASIC>                                           0
<EPS-DILUTED>                                         0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission